Cargando…
Novel insight into Chronic Inflammatory Demyelinating Polineuropathy in APECED syndrome: molecular mechanisms and clinical implications in children
Autoimmune polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) is a rare primary immunodeficiency disorder typically caused by homozygous AIRE gene mutation. It is characterized by the association of multiple autoimmune diseases, with a classical triad including chronic mucocutaneous candid...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347821/ https://www.ncbi.nlm.nih.gov/pubmed/28257655 http://dx.doi.org/10.1186/s13052-017-0331-6 |
_version_ | 1782514118238928896 |
---|---|
author | Valenzise, Mariella Aversa, Tommaso Salzano, Giuseppina Zirilli, Giuseppina De Luca, Filippo Su, Maureen |
author_facet | Valenzise, Mariella Aversa, Tommaso Salzano, Giuseppina Zirilli, Giuseppina De Luca, Filippo Su, Maureen |
author_sort | Valenzise, Mariella |
collection | PubMed |
description | Autoimmune polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) is a rare primary immunodeficiency disorder typically caused by homozygous AIRE gene mutation. It is characterized by the association of multiple autoimmune diseases, with a classical triad including chronic mucocutaneous candidiasis, hypoparathyroidism and adrenocortical failure. Its clinical spectrum has significantly enlarged in the last years with the apparence of new entities. One of these novel manifestations is the chronic inflammatory demyelinating polineuropathy (CIDP), that is characterized by involvement of peripheral nervous system, with nerve demyelination, progressive muscular weakness of both arms and legs and sensory loss. The identification of myelin protein zero as an important autoantigen (Ag) in CIDP may suggest the development of Ag-based therapies, such as Ag-specific DNA vaccination or infusion of Ag-coupled cells. |
format | Online Article Text |
id | pubmed-5347821 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53478212017-03-14 Novel insight into Chronic Inflammatory Demyelinating Polineuropathy in APECED syndrome: molecular mechanisms and clinical implications in children Valenzise, Mariella Aversa, Tommaso Salzano, Giuseppina Zirilli, Giuseppina De Luca, Filippo Su, Maureen Ital J Pediatr Commentary Autoimmune polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) is a rare primary immunodeficiency disorder typically caused by homozygous AIRE gene mutation. It is characterized by the association of multiple autoimmune diseases, with a classical triad including chronic mucocutaneous candidiasis, hypoparathyroidism and adrenocortical failure. Its clinical spectrum has significantly enlarged in the last years with the apparence of new entities. One of these novel manifestations is the chronic inflammatory demyelinating polineuropathy (CIDP), that is characterized by involvement of peripheral nervous system, with nerve demyelination, progressive muscular weakness of both arms and legs and sensory loss. The identification of myelin protein zero as an important autoantigen (Ag) in CIDP may suggest the development of Ag-based therapies, such as Ag-specific DNA vaccination or infusion of Ag-coupled cells. BioMed Central 2017-01-19 /pmc/articles/PMC5347821/ /pubmed/28257655 http://dx.doi.org/10.1186/s13052-017-0331-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Commentary Valenzise, Mariella Aversa, Tommaso Salzano, Giuseppina Zirilli, Giuseppina De Luca, Filippo Su, Maureen Novel insight into Chronic Inflammatory Demyelinating Polineuropathy in APECED syndrome: molecular mechanisms and clinical implications in children |
title | Novel insight into Chronic Inflammatory Demyelinating Polineuropathy in APECED syndrome: molecular mechanisms and clinical implications in children |
title_full | Novel insight into Chronic Inflammatory Demyelinating Polineuropathy in APECED syndrome: molecular mechanisms and clinical implications in children |
title_fullStr | Novel insight into Chronic Inflammatory Demyelinating Polineuropathy in APECED syndrome: molecular mechanisms and clinical implications in children |
title_full_unstemmed | Novel insight into Chronic Inflammatory Demyelinating Polineuropathy in APECED syndrome: molecular mechanisms and clinical implications in children |
title_short | Novel insight into Chronic Inflammatory Demyelinating Polineuropathy in APECED syndrome: molecular mechanisms and clinical implications in children |
title_sort | novel insight into chronic inflammatory demyelinating polineuropathy in apeced syndrome: molecular mechanisms and clinical implications in children |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347821/ https://www.ncbi.nlm.nih.gov/pubmed/28257655 http://dx.doi.org/10.1186/s13052-017-0331-6 |
work_keys_str_mv | AT valenzisemariella novelinsightintochronicinflammatorydemyelinatingpolineuropathyinapecedsyndromemolecularmechanismsandclinicalimplicationsinchildren AT aversatommaso novelinsightintochronicinflammatorydemyelinatingpolineuropathyinapecedsyndromemolecularmechanismsandclinicalimplicationsinchildren AT salzanogiuseppina novelinsightintochronicinflammatorydemyelinatingpolineuropathyinapecedsyndromemolecularmechanismsandclinicalimplicationsinchildren AT zirilligiuseppina novelinsightintochronicinflammatorydemyelinatingpolineuropathyinapecedsyndromemolecularmechanismsandclinicalimplicationsinchildren AT delucafilippo novelinsightintochronicinflammatorydemyelinatingpolineuropathyinapecedsyndromemolecularmechanismsandclinicalimplicationsinchildren AT sumaureen novelinsightintochronicinflammatorydemyelinatingpolineuropathyinapecedsyndromemolecularmechanismsandclinicalimplicationsinchildren |